speb/financial-data huggingface dataset:
PGEN income_statement (annual, 2023-12-31) — Basic Average Shares: 244536221.00
PGEN income_statement (annual, 2023-12-31) — Basic EPS: -0.39
PGEN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 48596000.00
PGEN balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 2629000.00
PGEN cash_flow (annual, 2023-12-31) — Capital Expenditure: -1536000.00
PGEN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 7097000.00
PGEN balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
PGEN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 7578000.00
PGEN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 62855000.00
PGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 29589000.00
PGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -3087000.00
PGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -66930000.00
PGEN cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: 0.00
PGEN cash_flow (annual, 2023-12-31) — Change In Account Payable: -2421000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 782000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Inventory: 0.00
PGEN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 129000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -107000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 5711000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Payable: -2421000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -1639000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 748000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Receivables: 12229000.00
PGEN cash_flow (annual, 2023-12-31) — Change In Working Capital: 17071000.00
PGEN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 76000.00
PGEN cash_flow (annual, 2023-12-31) — Changes In Cash: -40428000.00
PGEN balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
PGEN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 118498000.00
PGEN cash_flow (annual, 2023-12-31) — Common Stock Issuance: 72808000.00
PGEN cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
PGEN balance_sheet (annual, 2023-12-31) — Construction In Progress: 1577000.00
PGEN income_statement (annual, 2023-12-31) — Cost Of Revenue: 6119000.00
PGEN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 11298000.00
PGEN balance_sheet (annual, 2023-12-31) — Current Assets: 68755000.00
PGEN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1202000.00
PGEN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1202000.00
PGEN balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 509000.00
PGEN balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 509000.00
PGEN balance_sheet (annual, 2023-12-31) — Current Liabilities: 22985000.00
PGEN cash_flow (annual, 2023-12-31) — Deferred Income Tax: -479000.00
PGEN cash_flow (annual, 2023-12-31) — Deferred Tax: -479000.00
PGEN cash_flow (annual, 2023-12-31) — Depreciation: 1820000.00
PGEN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 6668000.00
PGEN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 6668000.00
PGEN balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 0.00
PGEN income_statement (annual, 2023-12-31) — Diluted Average Shares: 244536221.00
PGEN income_statement (annual, 2023-12-31) — Diluted EPS: -0.39
PGEN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -95904000.00
PGEN income_statement (annual, 2023-12-31) — EBIT: -95894000.00
PGEN income_statement (annual, 2023-12-31) — EBITDA: -89226000.00
PGEN income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 0.00
PGEN cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
PGEN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -320000.00
PGEN cash_flow (annual, 2023-12-31) — End Cash Position: 7848000.00
PGEN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 29589000.00
PGEN cash_flow (annual, 2023-12-31) — Free Cash Flow: -68466000.00
PGEN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -1947000.00
PGEN balance_sheet (annual, 2023-12-31) — Goodwill: 26612000.00
PGEN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 67313000.00
PGEN balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 1086000.00
PGEN balance_sheet (annual, 2023-12-31) — Gross PPE: 38412000.00
PGEN income_statement (annual, 2023-12-31) — Gross Profit: 106000.00
PGEN income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 10835000.00
PGEN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 21000.00
PGEN income_statement (annual, 2023-12-31) — Interest Expense: 468000.00
PGEN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 468000.00
PGEN income_statement (annual, 2023-12-31) — Interest Income: 3237000.00
PGEN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3237000.00
PGEN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1171000.00
PGEN balance_sheet (annual, 2023-12-31) — Invested Capital: 118498000.00
PGEN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -3087000.00
PGEN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 72808000.00
PGEN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
PGEN balance_sheet (annual, 2023-12-31) — Land And Improvements: 164000.00
PGEN balance_sheet (annual, 2023-12-31) — Leases: 4380000.00
PGEN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 5895000.00
PGEN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 5895000.00
PGEN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
PGEN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -43219000.00
PGEN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 3989000.00
PGEN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 72808000.00
PGEN cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PGEN income_statement (annual, 2023-12-31) — Net Income: -95904000.00
PGEN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -95904000.00
PGEN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -95904000.00
PGEN income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 0.00
PGEN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -95904000.00
PGEN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -95904000.00
PGEN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -95904000.00
PGEN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -95904000.00
PGEN income_statement (annual, 2023-12-31) — Net Interest Income: 2769000.00
PGEN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1649000.00
PGEN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -43219000.00
PGEN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -43219000.00
PGEN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 2769000.00
PGEN cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 98000.00
PGEN balance_sheet (annual, 2023-12-31) — Net PPE: 14129000.00
PGEN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1536000.00
PGEN cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
PGEN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 51185000.00
PGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 3665000.00
PGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 1818000.00
PGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 1847000.00
PGEN income_statement (annual, 2023-12-31) — Normalized EBITDA: -78391000.00
PGEN income_statement (annual, 2023-12-31) — Normalized Income: -85123175.00
PGEN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -66930000.00
PGEN cash_flow (annual, 2023-12-31) — Operating Gains Losses: -132000.00
PGEN income_statement (annual, 2023-12-31) — Operating Income: -88923000.00
PGEN income_statement (annual, 2023-12-31) — Operating Revenue: 6225000.00
PGEN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 248919096.00
PGEN balance_sheet (annual, 2023-12-31) — Other Current Assets: 4325000.00
PGEN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -1947000.00
PGEN income_statement (annual, 2023-12-31) — Other Income Expense: -10208000.00
PGEN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 40701000.00
PGEN cash_flow (annual, 2023-12-31) — Other Non Cash Items: -13068000.00
PGEN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 846000.00
PGEN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 627000.00
PGEN balance_sheet (annual, 2023-12-31) — Other Properties: 25673000.00
PGEN balance_sheet (annual, 2023-12-31) — Other Receivables: 673000.00
PGEN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 55277000.00
PGEN balance_sheet (annual, 2023-12-31) — Payables: 1726000.00
PGEN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 13024000.00
PGEN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8250000.00
PGEN balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 0.00
PGEN cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
PGEN income_statement (annual, 2023-12-31) — Pretax Income: -96362000.00
PGEN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
PGEN balance_sheet (annual, 2023-12-31) — Properties: 0.00
PGEN cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
PGEN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -185026000.00
PGEN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1536000.00
PGEN balance_sheet (annual, 2023-12-31) — Receivables: 1575000.00
PGEN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 6119000.00
PGEN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 6668000.00
PGEN cash_flow (annual, 2023-12-31) — Repayment Of Debt: -43219000.00
PGEN cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
PGEN income_statement (annual, 2023-12-31) — Research And Development: 48614000.00
PGEN balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
PGEN balance_sheet (annual, 2023-12-31) — Retained Earnings: -1964471000.00
PGEN cash_flow (annual, 2023-12-31) — Sale Of Investment: 183377000.00
PGEN income_statement (annual, 2023-12-31) — Selling General And Administration: 40415000.00
PGEN balance_sheet (annual, 2023-12-31) — Share Issued: 256398527.00
PGEN income_statement (annual, 2023-12-31) — Special Income Charges: -10835000.00
PGEN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 9888000.00
PGEN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 118498000.00
PGEN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 51185000.00
PGEN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -54175.00
PGEN income_statement (annual, 2023-12-31) — Tax Provision: -458000.00
PGEN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.01
PGEN balance_sheet (annual, 2023-12-31) — Total Assets: 151043000.00
PGEN balance_sheet (annual, 2023-12-31) — Total Capitalization: 118498000.00
PGEN balance_sheet (annual, 2023-12-31) — Total Debt: 7097000.00
PGEN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 118498000.00
PGEN income_statement (annual, 2023-12-31) — Total Expenses: 95148000.00
PGEN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 32545000.00
PGEN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 82288000.00
PGEN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 9560000.00
PGEN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -99758000.00
PGEN income_statement (annual, 2023-12-31) — Total Unusual Items: -10835000.00
PGEN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -10835000.00
PGEN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 7479431.00
PGEN balance_sheet (annual, 2023-12-31) — Working Capital: 45770000.00
PGEN cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
PGEN income_statement (quarterly, 2024-09-30) — Basic Average Shares: 275881170.00
PGEN income_statement (quarterly, 2024-09-30) — Basic EPS: -0.09
PGEN cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 31833000.00
PGEN income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 275881170.00
PGEN income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.09
PGEN income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
PGEN cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 0.00
PGEN cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 31833000.00
PGEN cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
PGEN cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
PGEN cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
PGEN cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 57000.00
PGEN balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 89000.00
PGEN cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
PGEN income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
PGEN balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 0.00
PGEN income_statement (annual, 2024-12-31) — +Operating Expense: 94363000.00
PGEN income_statement (annual, 2024-12-31) — +Total Revenue: 3925000.00
PGEN balance_sheet (annual, 2024-12-31) — Accounts Payable: 3531000.00
PGEN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 926000.00
PGEN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -22871000.00
PGEN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2129207000.00
PGEN balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
PGEN cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 3059000.00
PGEN cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 3059000.00
PGEN cash_flow (annual, 2024-12-31) — Amortization Of Securities: -883000.00
PGEN cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 40324000.00
PGEN cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 5779000.00
PGEN income_statement (annual, 2024-12-31) — Basic Average Shares: 267727426.00
PGEN income_statement (annual, 2024-12-31) — Basic EPS: -0.47
PGEN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 7848000.00
PGEN balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 2629000.00
PGEN cash_flow (annual, 2024-12-31) — Capital Expenditure: -8584000.00
PGEN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 5502000.00
PGEN balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 29517000.00
PGEN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 97910000.00
PGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 110583000.00
PGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -20714000.00
PGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -68173000.00
PGEN cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
PGEN cash_flow (annual, 2024-12-31) — Change In Account Payable: 1549000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -1827000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Inventory: 0.00
PGEN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 120000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -55000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 3341000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Payable: 1549000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -278000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 981000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Receivables: 414000.00
PGEN cash_flow (annual, 2024-12-31) — Change In Working Capital: 4523000.00
PGEN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -24000.00
PGEN cash_flow (annual, 2024-12-31) — Changes In Cash: 21696000.00
PGEN balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 38513000.00
PGEN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 31237000.00
PGEN cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: -596000.00
PGEN cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Construction In Progress: 9019000.00
PGEN income_statement (annual, 2024-12-31) — Cost Of Revenue: 4267000.00
PGEN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 8025000.00
PGEN balance_sheet (annual, 2024-12-31) — Current Assets: 102414000.00
PGEN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 956000.00
PGEN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 956000.00
PGEN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 589000.00
PGEN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 589000.00
PGEN balance_sheet (annual, 2024-12-31) — Current Liabilities: 21518000.00
PGEN cash_flow (annual, 2024-12-31) — Deferred Income Tax: -1795000.00
PGEN cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: -89000.00
PGEN cash_flow (annual, 2024-12-31) — Deferred Tax: -1795000.00
PGEN cash_flow (quarterly, 2024-12-31) — Deferred Tax: -89000.00
PGEN cash_flow (annual, 2024-12-31) — Depreciation: 1467000.00
PGEN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 4526000.00
PGEN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 4526000.00
PGEN balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 50537000.00
PGEN balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 50537000.00
PGEN income_statement (annual, 2024-12-31) — Diluted Average Shares: 267727426.00
PGEN income_statement (annual, 2024-12-31) — Diluted EPS: -0.47
PGEN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -126235000.00
PGEN income_statement (annual, 2024-12-31) — EBIT: -128022000.00
PGEN income_statement (annual, 2024-12-31) — EBITDA: -123496000.00
PGEN income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 0.00
PGEN cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
PGEN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -27000.00
PGEN cash_flow (annual, 2024-12-31) — End Cash Position: 29517000.00
PGEN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 110583000.00
PGEN balance_sheet (annual, 2024-12-31) — Finished Goods: 0.00
PGEN balance_sheet (quarterly, 2024-12-31) — Finished Goods: 0.00
PGEN cash_flow (annual, 2024-12-31) — Free Cash Flow: -76757000.00
PGEN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 12000.00
PGEN balance_sheet (annual, 2024-12-31) — Goodwill: 19139000.00
PGEN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 23594000.00
PGEN balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 926000.00
PGEN balance_sheet (annual, 2024-12-31) — Gross PPE: 41670000.00
PGEN income_statement (annual, 2024-12-31) — Gross Profit: -342000.00
PGEN income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 40324000.00
PGEN income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 5779000.00
PGEN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 4000.00
PGEN cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
PGEN income_statement (annual, 2024-12-31) — Interest Expense: 6000.00
PGEN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 6000.00
PGEN income_statement (annual, 2024-12-31) — Interest Income: 1418000.00
PGEN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1418000.00
PGEN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 7000.00
PGEN balance_sheet (annual, 2024-12-31) — Inventory: 0.00
PGEN balance_sheet (quarterly, 2024-12-31) — Inventory: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Invested Capital: 38513000.00
PGEN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -20714000.00
PGEN balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
PGEN balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
PGEN balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
PGEN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 110237000.00
PGEN cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 78404000.00
PGEN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Land And Improvements: 164000.00
PGEN balance_sheet (annual, 2024-12-31) — Leases: 4478000.00
PGEN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 4546000.00
PGEN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 4546000.00
PGEN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
PGEN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
PGEN cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3550000.00
PGEN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 31237000.00
PGEN cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 2915000.00
PGEN cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PGEN income_statement (annual, 2024-12-31) — Net Income: -126235000.00
PGEN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -126235000.00
PGEN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -126235000.00
PGEN income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
PGEN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -126235000.00
PGEN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -126235000.00
PGEN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -126235000.00
PGEN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -126235000.00
PGEN income_statement (annual, 2024-12-31) — Net Interest Income: 1412000.00
PGEN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -12190000.00
PGEN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
PGEN cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
PGEN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
PGEN cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
PGEN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1412000.00
PGEN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 60000.00
PGEN cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Net PPE: 18799000.00
PGEN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -8584000.00
PGEN cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 79000000.00
PGEN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 14919000.00
PGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1934000.00
PGEN balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 1934000.00
PGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 1934000.00
PGEN balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 1934000.00
PGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
PGEN balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
PGEN income_statement (annual, 2024-12-31) — Normalized EBITDA: -83172000.00
PGEN income_statement (annual, 2024-12-31) — Normalized Income: -86475536.00
PGEN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -68173000.00
PGEN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 2913000.00
PGEN cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 0.00
PGEN income_statement (annual, 2024-12-31) — Operating Income: -94705000.00
PGEN income_statement (annual, 2024-12-31) — Operating Revenue: 3925000.00
PGEN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 292869097.00
PGEN balance_sheet (annual, 2024-12-31) — Other Current Assets: 3341000.00
PGEN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 12000.00
PGEN income_statement (annual, 2024-12-31) — Other Income Expense: -34735000.00
PGEN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 4455000.00
PGEN cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1017000.00
PGEN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 459000.00
PGEN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 5589000.00
PGEN balance_sheet (annual, 2024-12-31) — Other Properties: 21830000.00
PGEN balance_sheet (annual, 2024-12-31) — Other Receivables: 237000.00
PGEN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 68393000.00
PGEN balance_sheet (annual, 2024-12-31) — Payables: 3531000.00
PGEN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 11556000.00
PGEN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8417000.00
PGEN balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 28218000.00
PGEN balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 28218000.00
PGEN cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 79000000.00
PGEN income_statement (annual, 2024-12-31) — Pretax Income: -128028000.00
PGEN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 346000.00
PGEN balance_sheet (annual, 2024-12-31) — Properties: 0.00
PGEN cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 0.00
PGEN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -187206000.00
PGEN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -8584000.00
PGEN balance_sheet (annual, 2024-12-31) — Raw Materials: 0.00
PGEN balance_sheet (quarterly, 2024-12-31) — Raw Materials: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Receivables: 1163000.00
PGEN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 4267000.00
PGEN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 4526000.00
PGEN cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
PGEN cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
PGEN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
PGEN income_statement (annual, 2024-12-31) — Research And Development: 53070000.00
PGEN balance_sheet (annual, 2024-12-31) — Retained Earnings: -2090706000.00
PGEN cash_flow (annual, 2024-12-31) — Sale Of Investment: 175016000.00
PGEN income_statement (annual, 2024-12-31) — Selling General And Administration: 41293000.00
PGEN balance_sheet (annual, 2024-12-31) — Share Issued: 292869097.00
PGEN income_statement (annual, 2024-12-31) — Special Income Charges: -40324000.00
PGEN income_statement (quarterly, 2024-12-31) — Special Income Charges: -5779000.00
PGEN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 9471000.00
PGEN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 38513000.00
PGEN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 14919000.00
PGEN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -564536.00
PGEN income_statement (annual, 2024-12-31) — Tax Provision: -1793000.00
PGEN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.01
PGEN balance_sheet (annual, 2024-12-31) — Total Assets: 145266000.00
PGEN balance_sheet (annual, 2024-12-31) — Total Capitalization: 38513000.00
PGEN balance_sheet (annual, 2024-12-31) — Total Debt: 5502000.00
PGEN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 38513000.00
PGEN income_statement (annual, 2024-12-31) — Total Expenses: 98630000.00
PGEN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 106753000.00
PGEN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 42852000.00
PGEN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 85235000.00
PGEN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -135029000.00
PGEN income_statement (annual, 2024-12-31) — Total Unusual Items: -40324000.00
PGEN income_statement (quarterly, 2024-12-31) — Total Unusual Items: -5779000.00
PGEN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -40324000.00
PGEN income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -5779000.00
PGEN balance_sheet (annual, 2024-12-31) — Work In Process: 0.00
PGEN balance_sheet (quarterly, 2024-12-31) — Work In Process: 0.00
PGEN balance_sheet (annual, 2024-12-31) — Working Capital: 80896000.00
PGEN income_statement (quarterly, 2025-03-31) — +Operating Expense: 22837000.00
PGEN income_statement (quarterly, 2025-03-31) — +Total Revenue: 1341000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3107000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 751000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -23180000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2130787000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
PGEN cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 319000.00
PGEN cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 319000.00
PGEN cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -706000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 750000.00
PGEN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 293879653.00
PGEN income_statement (quarterly, 2025-03-31) — Basic EPS: -0.18
PGEN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 29517000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 2629000.00
PGEN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -622000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 5417000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
PGEN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 6058000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 80242000.00
PGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -679000.00
PGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -6457000.00
PGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -16325000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -117000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1277000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -56000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -95000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 1066000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Payable: -117000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1160000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 46000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 99000.00
PGEN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2220000.00
PGEN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 175000.00
PGEN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -23461000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
PGEN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -14060000.00
PGEN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -355000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 10131000.00
PGEN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1100000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 9781000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Current Assets: 84601000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 928000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 928000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 549000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 549000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 23986000.00
PGEN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
PGEN cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
PGEN cash_flow (quarterly, 2025-03-31) — Depreciation: 310000.00
PGEN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 629000.00
PGEN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 629000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 83018000.00
PGEN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 293879653.00
PGEN income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.18
PGEN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -54153000.00
PGEN income_statement (quarterly, 2025-03-31) — EBIT: -54152000.00
PGEN income_statement (quarterly, 2025-03-31) — EBITDA: -53523000.00
PGEN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 2000.00
PGEN cash_flow (quarterly, 2025-03-31) — End Cash Position: 6058000.00
PGEN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -679000.00
PGEN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -16947000.00
PGEN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 32481000.00
PGEN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -32481000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 12000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Goodwill: 19139000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 23275000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 751000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 42824000.00
PGEN income_statement (quarterly, 2025-03-31) — Gross Profit: 241000.00
PGEN income_statement (quarterly, 2025-03-31) — Interest Expense: 1000.00
PGEN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1000.00
PGEN income_statement (quarterly, 2025-03-31) — Interest Income: 918000.00
PGEN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 918000.00
PGEN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
PGEN balance_sheet (quarterly, 2025-03-31) — Invested Capital: -14060000.00
PGEN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -6457000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 750000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 750000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 164000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Leases: 4487000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 4489000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4489000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3574000.00
PGEN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -355000.00
PGEN income_statement (quarterly, 2025-03-31) — Net Income: -54153000.00
PGEN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -54153000.00
PGEN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -54153000.00
PGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -54153000.00
PGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -54153000.00
PGEN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -54153000.00
PGEN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -54153000.00
PGEN income_statement (quarterly, 2025-03-31) — Net Interest Income: 917000.00
PGEN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -5835000.00
PGEN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 917000.00
PGEN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -474000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Net PPE: 19644000.00
PGEN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -622000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -37335000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1836000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 1836000.00
PGEN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -21042000.00
PGEN income_statement (quarterly, 2025-03-31) — Normalized Income: -21672000.00
PGEN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -16325000.00
PGEN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 32481000.00
PGEN income_statement (quarterly, 2025-03-31) — Operating Income: -22596000.00
PGEN income_statement (quarterly, 2025-03-31) — Operating Revenue: 1341000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 295135060.00
PGEN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3295000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 12000.00
PGEN income_statement (quarterly, 2025-03-31) — Other Income Expense: -32474000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 4136000.00
PGEN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 527000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 517000.00
PGEN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 7000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Other Properties: 21839000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 313000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 74184000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Payables: 3107000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 12888000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9621000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 29518000.00
PGEN income_statement (quarterly, 2025-03-31) — Pretax Income: -54153000.00
PGEN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 150000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PGEN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -10408000.00
PGEN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -622000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Receivables: 1064000.00
PGEN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1100000.00
PGEN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 629000.00
PGEN cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -355000.00
PGEN income_statement (quarterly, 2025-03-31) — Research And Development: 10478000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -2144859000.00
PGEN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 4573000.00
PGEN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 12359000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Share Issued: 295135060.00
PGEN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2677000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -14060000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -37335000.00
PGEN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PGEN income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
PGEN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
PGEN balance_sheet (quarterly, 2025-03-31) — Total Assets: 128787000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -14060000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Total Debt: 5417000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -14060000.00
PGEN income_statement (quarterly, 2025-03-31) — Total Expenses: 23937000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 142847000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 44186000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 118861000.00
PGEN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -22596000.00
PGEN income_statement (quarterly, 2025-03-31) — Total Unusual Items: -32481000.00
PGEN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -32481000.00
PGEN balance_sheet (quarterly, 2025-03-31) — Working Capital: 60615000.00
PGEN income_statement (quarterly, 2025-06-30) — +Operating Expense: 27621000.00
PGEN income_statement (quarterly, 2025-06-30) — +Total Revenue: 856000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3922000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 327000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -22515000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2134711000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: 0.00
PGEN cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 318000.00
PGEN cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 318000.00
PGEN cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -468000.00
PGEN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 296434726.00
PGEN income_statement (quarterly, 2025-06-30) — Basic EPS: -0.09
PGEN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 6058000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 2629000.00
PGEN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -966000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 5153000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
PGEN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 13760000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 59753000.00
PGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1766000.00
PGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 28442000.00
PGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -18977000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 801000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 4101000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -159000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -4000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 305000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Payable: 801000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 4902000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 864000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Receivables: 496000.00
PGEN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 6404000.00
PGEN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 424000.00
PGEN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 7699000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
PGEN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -36779000.00
PGEN cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
PGEN balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 10443000.00
PGEN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1092000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 12727000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Current Assets: 62755000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 930000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 930000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 413000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 413000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 23193000.00
PGEN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 0.00
PGEN cash_flow (quarterly, 2025-06-30) — Deferred Tax: 0.00
PGEN cash_flow (quarterly, 2025-06-30) — Depreciation: 312000.00
PGEN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 630000.00
PGEN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 630000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 78558000.00
PGEN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 296434726.00
PGEN income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.09
PGEN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -26642000.00
PGEN income_statement (quarterly, 2025-06-30) — EBIT: -26639000.00
PGEN income_statement (quarterly, 2025-06-30) — EBITDA: -26009000.00
PGEN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 3000.00
PGEN cash_flow (quarterly, 2025-06-30) — End Cash Position: 13760000.00
PGEN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1766000.00
PGEN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -19943000.00
PGEN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -4460000.00
PGEN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 4460000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 11000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Goodwill: 15232000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 19050000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 327000.00
PGEN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 41944000.00
PGEN income_statement (quarterly, 2025-06-30) — Gross Profit: -236000.00
PGEN income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 3907000.00
PGEN income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
PGEN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
PGEN income_statement (quarterly, 2025-06-30) — Interest Income: 696000.00
PGEN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 696000.00
PGEN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
PGEN balance_sheet (quarterly, 2025-06-30) — Invested Capital: -36779000.00
PGEN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 28442000.00